{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:29:02Z","timestamp":1780414142607,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10549-025-07657-y","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:54:17Z","timestamp":1740696857000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High risk surveillance MRI may not be necessary in BRCA1\/2 mutation carriers over 70\u00a0years old"],"prefix":"10.1007","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0621-980X","authenticated-orcid":false,"given":"Astrid","family":"Botty van den Bruele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koumani W.","family":"Ntowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars J.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"7657_CR1","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (2020) Breast cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf Accessed Feb 11 2020"},{"key":"7657_CR2","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risk of breast, ovarian and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416","journal-title":"JAMA"},{"issue":"5","key":"7657_CR3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"6","key":"7657_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/cncr.34615","volume":"129","author":"KA Metcalfe","year":"2023","unstructured":"Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, Eng C, Pal T, Cullinane CA, Couch FJ, Kotsopoulos J, Sun P, Lubinski J, Narod SA (2023) The risks of cancer in older women with BRCA pathogenic variants: how far have we come? Cancer 129(6):901\u2013907. https:\/\/doi.org\/10.1002\/cncr.34615","journal-title":"Cancer"},{"key":"7657_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1200\/JCO.2014.56.6232","volume":"33","author":"XA Phi","year":"2015","unstructured":"Phi XA, Houssami N, Obdeijn IM et al (2015) Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers > age 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol 33:349\u2013356","journal-title":"J Clin Oncol"},{"issue":"6","key":"7657_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/bjc.2016.32","volume":"114","author":"XA Phi","year":"2016","unstructured":"Phi XA, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Hooning MJ, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, Tilanus-Linthorst MM, van den Heuvel ER, Houssami N (2016) Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer 114(6):631\u2013637. https:\/\/doi.org\/10.1038\/bjc.2016.32","journal-title":"Br J Cancer"},{"key":"7657_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.293.10.1245","volume":"293","author":"JG Elmore","year":"2005","unstructured":"Elmore JG, Armstrong K, Lehman CD et al (2005) Screening for breast cancer. JAMA 293:1245\u20131256","journal-title":"JAMA"},{"key":"7657_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1054\/brst.2001.0391","volume":"11","author":"N Houssami","year":"2002","unstructured":"Houssami N, Ciatto S, Irwig L et al (2002) The comparative sensitivity of mammography and ultrasound in women with breast symptoms: an age specific analysis. Breast 11:125\u2013130","journal-title":"Breast"},{"issue":"3","key":"7657_CR9","doi-asserted-by":"publisher","first-page":"W292","DOI":"10.2214\/AJR.10.6049","volume":"198","author":"CM Checka","year":"2012","unstructured":"Checka CM, Chun JE, Schnabel FR, Lee J, Toth H (2012) The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 198(3):W292\u2013W295. https:\/\/doi.org\/10.2214\/AJR.10.6049","journal-title":"AJR Am J Roentgenol"},{"issue":"33","key":"7657_CR10","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1200\/JCO.2008.21.5756","volume":"27","author":"ME Brennan","year":"2009","unstructured":"Brennan ME, Houssami N, Lord S et al (2009) Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and metaanalysis of incremental cancer detection and impact on surgical management. J Clin Oncol 27(33):5640\u20135649","journal-title":"J Clin Oncol"},{"issue":"9","key":"7657_CR11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/JCO.22.01239","volume":"41","author":"S Yadav","year":"2023","unstructured":"Yadav S, Boddicker NJ, Na J, Polley EC, Hu C, Hart SN, Gnanaolivu RD, Larson N, Holtegaard S, Huang H, Dunn CA, Teras LR, Patel AV, Lacey JV, Neuhausen SL, Martinez E, Haiman C, Chen F, Ruddy KJ, Olson JE, John EM, Kurian AW, Sandler DP, O\u2019Brien KM, Taylor JA, Weinberg CR, Anton-Culver H, Ziogas A, Zirpoli G, Goldgar DE, Palmer JR, Domchek SM, Weitzel JN, Nathanson KL, Kraft P, Couch FJ (2023) Contralateral breast cancer risk among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin Oncol 41(9):1703\u20131713. https:\/\/doi.org\/10.1200\/JCO.22.01239","journal-title":"J Clin Oncol"},{"key":"7657_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1200\/JCO.2009.24.2495","volume":"28","author":"KE Malone","year":"2010","unstructured":"Malone KE et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. JCO 28:2404\u20132410. https:\/\/doi.org\/10.1200\/JCO.2009.24.2495","journal-title":"JCO"},{"issue":"9","key":"7657_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","volume":"13","author":"N Tung","year":"2016","unstructured":"Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, Offit K, Robson ME (2016) Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol 13(9):581\u2013588. https:\/\/doi.org\/10.1038\/nrclinonc.2016.90","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"7657_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-017-4476-1","volume":"167","author":"V Giannakeas","year":"2018","unstructured":"Giannakeas V, Narod SA (2018) The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy. Breast Cancer Res Treat 167(1):263\u2013267. https:\/\/doi.org\/10.1007\/s10549-017-4476-1","journal-title":"Breast Cancer Res Treat"},{"key":"7657_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"7657_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S1470-2045(19)30275-X","volume":"20","author":"S Saadatmand","year":"2019","unstructured":"Saadatmand S, Geuzinge HA, Rutgers EJT, Mann RM, de Zuidewijn DBW, Zonderland HM, Tollenaar RAEM, Lobbes MBI, Ausems MGEM, van\u2019t Riet M, Hooning MJ, Mares-Engelberts I, Luiten EJT, Heijnsdijk EAM, Verhoef C, Karssemeijer N, Oosterwijk JC, de Obdeijn IM, Koning HJ (2019) Tilanus-linthorst MMA; FaMRIsc study group MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet Oncol 20(8):1136\u20131147. https:\/\/doi.org\/10.1016\/S1470-2045(19)30275-X","journal-title":"Lancet Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07657-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T03:16:20Z","timestamp":1744859780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07657-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7657"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07657-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.Dr. Plichta was the recipient of research funding from the Color Foundation (2017-2018; PI: Plichta) and Earlier.org (2023-2024; PI: Plichta). She is a member of Editorial Committee for the American Joint Committee on Cancer (AJCC), the Breast Panel for the AJCC, and the National Comprehensive Cancer Network (NCCN) Breast Cancer Diagnosis and Screening Committee. Dr. L.H. Rosenberger serves on the NCCN Breast Cancer Committee. S. Thomas is a member of the Evidence-Based Medicine Committee for the AJCC, the Breast Panel for the AJCC, and the Neuroendocrine Tumors Panel for the AJCC. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}